Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | THRB | P10828 | 1/20 | 0.39 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.35 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.35 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.35 |
| ▸ | MMP1 | P03956 | 1/20 | 0.30 |
| ▸ | MMP2 | P08253 | 1/20 | 0.30 |
| ▸ | MMP3 | P08254 | 1/20 | 0.30 |
| ▸ | MMP13 | P45452 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL52628 | 0.79 | THRB (0.49) | THRBCYP3A4CYP2C9CYP2C19MMP1 | |
| SCHEMBL21996075 | 0.76 | — | — | |
| SCHEMBL2488687 | 0.76 | THRB (0.42) | THRBCYP3A4CYP2C9CYP2C19MMP1 | |
| SCHEMBL25660393 | 0.76 | THRB (0.39) | THRBCYP2C9CYP2C19 | |
| SCHEMBL15778131 | 0.73 | — | — | |
| SCHEMBL4948620 | 0.72 | — | — | |
| SCHEMBL7765194 | 0.70 | MMP1 (0.35) | THRBCYP3A4CYP2C9CYP2C19MMP1 | |
| SCHEMBL26870655 | 0.69 | — | — | |
| SCHEMBL8496307 | 0.68 | THRB (0.36) | THRBCYP3A4CYP2C9CYP2C19 | |
| SCHEMBL27656105 | 0.68 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6825375-B2 | REACTING 2-CYCLOPENTEN-1-ONE WITH FLUOROKETENE SILYL ACETAL; CENTRAL NERVOUS SYSTEM DISORDERS; PSYCHOLOGICAL DISORDERS | TAISHO PHARMACEUTICAL CO. (JP) | 2004-11-30 | — | — | US | claimed |
| US-20030171431-A1 | Intermediate and process for producing fluorinated carboxylic acid derivative from the same | TAISHO PHARMACUETICAL CO., LTD. (JP) | 2003-09-11 | — | — | US | claimed |
| EP-1295862-A1 | INTERMEDIATE AND PROCESS FOR PRODUCING FLUORINATED CARBOXYLIC ACID DERIVATIVE FROM THE SAME | TAISHO PHARMACEUTICAL CO., LTD (JP) | 2003-03-26 | — | — | EP | claimed |
| EP-1295862-A4 | INTERMEDIATE AND PROCESS FOR PRODUCING FLUORINATED CARBOXYLIC ACID DERIVATIVE FROM THE SAME | TAISHO PHARMACEUTICAL CO LTD (JP) | 2005-09-28 | — | — | EP | disclosed |
| CN-1203044-C | Intermediate and process for producing fluorinated carboxylic acid derivative from the same | TAISHO PHARMACEUTICAL CO LTD (JP) | 2005-05-25 | — | — | CN | disclosed |
| US-6825375-B2 | REACTING 2-CYCLOPENTEN-1-ONE WITH FLUOROKETENE SILYL ACETAL; CENTRAL NERVOUS SYSTEM DISORDERS; PSYCHOLOGICAL DISORDERS | TAISHO PHARMACEUTICAL CO. (JP) | 2004-11-30 | — | — | US | disclosed |
| CN-1446191-A | Intermediate and process for producing fluorinated carboxylic acid derivative from the same | TAISHO PHARMACEUTICAL CO LTD (JP) | 2003-10-01 | — | — | CN | disclosed |
| US-20030171431-A1 | Intermediate and process for producing fluorinated carboxylic acid derivative from the same | TAISHO PHARMACUETICAL CO., LTD. (JP) | 2003-09-11 | — | — | US | disclosed |
| EP-1295862-A1 | INTERMEDIATE AND PROCESS FOR PRODUCING FLUORINATED CARBOXYLIC ACID DERIVATIVE FROM THE SAME | TAISHO PHARMACEUTICAL CO., LTD (JP) | 2003-03-26 | — | — | EP | disclosed |
| WO-2002000595-A1 | INTERMEDIATE AND PROCESS FOR PRODUCING FLUORINATED CARBOXYLIC ACID DERIVATIVE FROM THE SAME | TAISHO PHARMACEUTICAL CO., LTD. (JP) | 2002-01-03 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030171431-A1 | Intermediate and process for producing fluorinated carboxylic acid derivative from the same | ALDH7A1, ACACA, FDPS | THRB 3440/4885CYP3A4 146/4885CYP2C9 214/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.